A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults-Reference-Cited by-同舟云学术

A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults

Published:2024-04-01 Issue:7 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Tiono Alfred B.,Plieskatt Jordan L.,Ouedraogo Alphonse,Soulama Ben Idriss,Miura Kazutoyo^ORCID,Bougouma Edith C.,Naghizadeh Mohammad,Barry Aissata,Yaro Jean Baptist B.,Ezinmegnon Sem,Henry Noelie,Ofori Ebenezer Addo,Adu Bright,Singh Susheel K.,Konkobo Augustin,Lövgren Bengtsson Karin,Diarra Amidou,Carnrot Cecilia,Reimer Jenny M.,Ouedraogo Amidou,Tienta Moussa,Long Carole A.^ORCID,Ouedraogo Issa N.,Sagara Issaka^ORCID,Sirima Sodiomon B.,Theisen Michael

Funder

European Union and Developing Countries Clinical Trials Partnership

Publisher

American Society for Clinical Investigation

Link

https://www.jci.org/articles/view/175707/files/pdf

Reference37 articles.

1. Tools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria?

2. Malaria transmission-blocking vaccines—how can their development be supported?

3. A Central Role for P48/45 in Malaria Parasite Male Gamete Fertility

4. Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum

5. Target antigens of malaria transmission blocking immunity exist as a stable membrane bound complex

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgM plays a prominent role in naturally acquired immunity againstPlasmodium falciparumgametocytes;2024-07-02

2. Quest for malaria management using natural remedies;Frontiers in Pharmacology;2024-06-26